• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期坚持使用可穿戴设备对SafeHeart植入式心脏复律除颤器人群的行为活动进行持续测量。

Long-term adherence to a wearable for continuous behavioural activity measuring in the SafeHeart implantable cardioverter defibrillator population.

作者信息

Frodi Diana My, Kolk Maarten Z H, Langford Joss, Knops Reinoud, Tan Hanno L, Andersen Tariq Osman, Jacobsen Peter Karl, Risum Niels, Svendsen Jesper Hastrup, Tjong Fleur V Y, Diederichsen Søren Zöga

机构信息

Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Inge Lehmanns Vej 7, DK-2100 Copenhagen, Denmark.

Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

出版信息

Eur Heart J Digit Health. 2024 Aug 1;5(5):622-632. doi: 10.1093/ehjdh/ztae055. eCollection 2024 Sep.

DOI:10.1093/ehjdh/ztae055
PMID:39318686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11417489/
Abstract

AIMS

Wearable health technologies are increasingly popular. Yet, wearable monitoring only works when devices are worn as intended, and adherence reporting lacks standardization. In this study, we aimed to explore the long-term adherence to a wrist-worn activity tracker in the prospective SafeHeart study and identify patient characteristics associated with adherence.

METHODS AND RESULTS

This study enrolled 303 participants, instructed to wear a wrist-worn accelerometer day and night for 6 months. Long-term adherence was defined as valid days (≥22 h of wear time) divided by expected days, and daily adherence as mean hours of wear time per 24 h period. Optimal, moderate, and low long-term and daily adherence groups were defined as long-term adherence above or below 95 and 75% and daily adherence above or below 90 and 75%. Regression models were used to identify patient characteristics associated with long-term adherence. In total, 296 participants [median age 64 years; interquartile range (IQR) 57-72; 19% female] were found eligible, yielding 44 003 days for analysis. The median long-term adherence was 88.2% (IQR 74.6-96.5%). A total of 83 (28%), 127 (42.9%), and 86 (29.1%) participants had optimal, moderate, and low long-term adherence, and 163 (55.1%), 87 (29.4%), and 46 (15.5%) had optimal, moderate, and low daily adherence, respectively. Age and smoking habits differed significantly between adherence levels, and increasing changeover intervals improved the degree of long-term adherence.

CONCLUSION

Long-term adherence to a wearable activity tracker was 88.2% over a 6-month period. Older age and longer changeover interval were positively associated with long-term adherence. This serves as a benchmark for future studies that rely on wearable devices.

TRIAL REGISTRATION NUMBER

The National Trial Registration number: NL9218 (https://onderzoekmetmensen.nl/).

摘要

目的

可穿戴健康技术越来越受欢迎。然而,可穿戴监测只有在设备按预期佩戴时才有效,且依从性报告缺乏标准化。在本研究中,我们旨在探讨前瞻性SafeHeart研究中对腕戴式活动追踪器的长期依从性,并确定与依从性相关的患者特征。

方法与结果

本研究招募了303名参与者,指示他们日夜佩戴腕戴式加速度计6个月。长期依从性定义为有效天数(佩戴时间≥22小时)除以预期天数,每日依从性定义为每24小时期间的平均佩戴小时数。最佳、中度和低度长期及每日依从性组定义为长期依从性高于或低于95%和75%,以及每日依从性高于或低于90%和75%。使用回归模型确定与长期依从性相关的患者特征。总共发现296名参与者[中位年龄64岁;四分位间距(IQR)57 - 72;19%为女性]符合条件,产生44003天用于分析。长期依从性的中位数为88.2%(IQR 74.6 - 96.5%)。共有83名(28%)、127名(42.9%)和86名(29.1%)参与者具有最佳、中度和低度长期依从性,以及163名(55.1%)、87名(29.4%)和46名(15.5%)参与者分别具有最佳、中度和低度每日依从性。依从性水平之间的年龄和吸烟习惯差异显著,且更换间隔时间增加可提高长期依从性程度。

结论

在6个月期间,对可穿戴活动追踪器的长期依从性为88.2%。年龄较大和更换间隔时间较长与长期依从性呈正相关。这为未来依赖可穿戴设备的研究提供了一个基准。

试验注册号

国家试验注册号:NL9218(https://onderzoekmetmensen.nl/)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/b25cb0c88ff4/ztae055f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/5d5f7b50c8ea/ztae055_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/1d0401107470/ztae055f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/1b4092517da5/ztae055f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/4a1db6786319/ztae055f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/b25cb0c88ff4/ztae055f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/5d5f7b50c8ea/ztae055_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/1d0401107470/ztae055f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/1b4092517da5/ztae055f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/4a1db6786319/ztae055f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bee0/11417489/b25cb0c88ff4/ztae055f4.jpg

相似文献

1
Long-term adherence to a wearable for continuous behavioural activity measuring in the SafeHeart implantable cardioverter defibrillator population.长期坚持使用可穿戴设备对SafeHeart植入式心脏复律除颤器人群的行为活动进行持续测量。
Eur Heart J Digit Health. 2024 Aug 1;5(5):622-632. doi: 10.1093/ehjdh/ztae055. eCollection 2024 Sep.
2
Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.用于为囊性纤维化患者提供和监测运动方案的数字技术。
Cochrane Database Syst Rev. 2023 Jun 9;6(6):CD014605. doi: 10.1002/14651858.CD014605.pub2.
3
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
4
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
5
Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.老年患者穿戴式除颤器的应用经验:来自穿戴式除颤器患者前瞻性注册研究的结果。
Heart Rhythm. 2018 Sep;15(9):1379-1386. doi: 10.1016/j.hrthm.2018.04.014. Epub 2018 Apr 18.
6
Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.使用可穿戴式除颤器管理心脏结节病中的心脏性猝死。
PLoS One. 2018 Mar 22;13(3):e0194496. doi: 10.1371/journal.pone.0194496. eCollection 2018.
7
Physical Activity Pattern of Adults With Metabolic Syndrome Risk Factors: Time-Series Cluster Analysis.代谢综合征风险因素成年人的体力活动模式:时间序列聚类分析。
JMIR Mhealth Uhealth. 2023 Dec 1;11:e50663. doi: 10.2196/50663.
8
Fitbit Use and Activity Levels From Intervention to 2 Years After: Secondary Analysis of a Randomized Controlled Trial.Fitbit 使用情况和活动水平:一项随机对照试验干预后 2 年的二次分析。
JMIR Mhealth Uhealth. 2022 Jun 30;10(6):e37086. doi: 10.2196/37086.
9
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).可穿戴式心脏除颤器在高危心脏患者中的应用:来自前瞻性可穿戴式心脏除颤器(WEARIT-II 注册研究)患者使用登记数据库的数据。
Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.
10
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart study.行为数字化生物标志物可实现患者报告结局的实时监测:多中心前瞻性观察性 SafeHeart 研究的子研究。
Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):531-542. doi: 10.1093/ehjqcco/qcad069.

引用本文的文献

1
Evaluating compliance with HeatSuite for monitoring in situ physiological and perceptual responses and personal environmental exposure.评估使用HeatSuite监测原位生理和感知反应以及个人环境暴露的依从性。
NPJ Digit Med. 2025 Apr 24;8(1):223. doi: 10.1038/s41746-025-01608-z.
2
From Wristbands to Implants: The Transformative Role of Wearables in Heart Failure Care.从腕带到植入物:可穿戴设备在心力衰竭护理中的变革性作用。
Healthcare (Basel). 2024 Dec 20;12(24):2572. doi: 10.3390/healthcare12242572.

本文引用的文献

1
Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac Death.植入式心脏复律除颤器用于心脏性猝死二级预防患者的预后性别差异
J Cardiovasc Dev Dis. 2024 Apr 5;11(4):116. doi: 10.3390/jcdd11040116.
2
Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants.植入起搏器、心脏再同步治疗装置或除颤器的已知心力衰竭患者的年龄分层临床结局。
Cardiology. 2024;149(5):474-483. doi: 10.1159/000538529. Epub 2024 Mar 30.
3
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart study.
行为数字化生物标志物可实现患者报告结局的实时监测:多中心前瞻性观察性 SafeHeart 研究的子研究。
Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):531-542. doi: 10.1093/ehjqcco/qcad069.
4
Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis.心血管疾病和 2 型糖尿病药物依从性测量工具的测量属性质量:系统评价和荟萃分析。
Syst Rev. 2023 Nov 22;12(1):222. doi: 10.1186/s13643-023-02340-z.
5
Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者发生心房颤动及不良结局的风险
Korean Circ J. 2024 Jan;54(1):13-27. doi: 10.4070/kcj.2023.0084. Epub 2023 Sep 19.
6
Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study.参与者参与度和对提供智能手表和患者报告结局数据的依从性:类风湿关节炎纵向数字追踪(DIGITAL)真实世界研究。
JMIR Hum Factors. 2023 Nov 7;10:e44034. doi: 10.2196/44034.
7
Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations.患者在临床护理中对患者报告结局测量(PROM)完成的依从性:当前的理解和未来的建议。
Qual Life Res. 2024 Jan;33(1):281-290. doi: 10.1007/s11136-023-03505-y. Epub 2023 Sep 11.
8
Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020.2019 年至 2020 年美国心血管疾病患者或心血管疾病风险人群使用可穿戴设备的情况。
JAMA Netw Open. 2023 Jun 1;6(6):e2316634. doi: 10.1001/jamanetworkopen.2023.16634.
9
Wearable Devices in Cardiovascular Medicine.可穿戴设备在心血管医学中的应用
Circ Res. 2023 Mar 3;132(5):652-670. doi: 10.1161/CIRCRESAHA.122.322389. Epub 2023 Mar 2.
10
Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.用于检测近期复发性房颤的移动健康依从性
Heart. 2022 Dec 13;109(1):26-33. doi: 10.1136/heartjnl-2022-321346.